Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

NCT00143377 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence

Interventions

DRUG: tolterodine SR, overactive bladder

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Collaborators

[object Object]